What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?

被引：4
|
作者：
Eleftheriadis, Theodoros [1 ]
机构：
[1] Univ Thessaly, Fac Med, Dept Nephrol, Larisa, Greece
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
关键词：
indoleamine; 2; 3-dioxygenase; cancer immunotherapy; p53; metabolism; T-cell; CD4(+) T-CELLS; TRYPTOPHAN DEPLETION; INTERFERON-GAMMA; GCN2; KINASE; SURVIVAL; EXPRESSION; INDOLEAMINE-2,3-DIOXYGENASE; PROLIFERATION; GLYCOLYSIS; INDUCTION;
D O I：
10.3389/fimmu.2018.01879
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [2] Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
    Guo, Yixuan
    Liu, Yu
    Wu, Wei
    Ling, Daishun
    Zhang, Qiao
    Zhao, Peng
    Hu, Xi
    BIOMATERIALS, 2021, 276
  • [3] Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
    Zulfiqar, Bilal
    Mahroo, Amnah
    Nasir, Kaenat
    Farooq, Rai Khalid
    Jalal, Nasir
    Rashid, Muhammad Usman
    Asghar, Kashif
    ONCOTARGETS AND THERAPY, 2017, 10 : 463 - 476
  • [4] Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy
    Weng, Tianwei
    Qiu, Xiaqiu
    Wang, Jubo
    Li, Zhiyu
    Bian, Jinlei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 656 - 669
  • [5] Research progress of indoleamine 2,3-dioxygenase inhibitors
    Jiang, Tianze
    Sun, Yingying
    Yin, Zhichao
    Feng, Sen
    Sun, Liping
    Li, Zhiyu
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (02) : 185 - 201
  • [6] Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
    Yoshioka, Saeko
    Ikeda, Tomonori
    Fukuchi, Sogo
    Kawai, Yurika
    Ohta, Katsumi
    Murakami, Hisashi
    Ogo, Naohisa
    Muraoka, Daisuke
    Takikawa, Osamu
    Asai, Akira
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2022, 15
  • [7] Indoleamine 2,3-dioxygenase, Tregs and Cancer
    Munn, D. H.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (15) : 2240 - 2246
  • [8] Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase
    Li, Yuanyuan
    Zhang, Shengnan
    Wang, Rong
    Cui, Menghan
    Liu, Wei
    Yang, Qing
    Kuang, Chunxiang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (11)
  • [9] Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
    Yentz, Sarah
    Smith, David
    BIODRUGS, 2018, 32 (04) : 311 - 317
  • [10] Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
    Bakmiwewa, Supun M.
    Fatokun, Amos A.
    Anh Tran
    Payne, Richard J.
    Hunt, Nicholas H.
    Ball, Helen J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7641 - 7646
12345